Home › Funds › JW Asset Management, LLC › HRTX
JW Asset Management, LLC position in HRTX
HERON THERAPEUTICS INC · Health Care
JW Asset Management, LLC reported holding 140,863 shares of HRTX (HERON THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$44K, representing 0.02% of its reported portfolio and ranking #29 among its reported holdings. JW Asset Management, LLC has disclosed HRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How JW Asset Management, LLC's HRTX position evolved
JW Asset Management, LLC first disclosed a stake in HRTX in Q3 2023 at 2,407,418 shares (US$2.5M). The position peaked in Q2 2024 at 2,292,418 shares, worth US$8.0M. Across 13 filings, JW Asset Management, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 140,863 shares valued at US$44K — a reduction of -3,610,210 shares quarter over quarter.. Notable position changes include a 41% increase in Q3 2025 (shares rose 3% over the following quarter), a 96% trim in Q3 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.41M | $2.48M | New |
| Q4 2023 | 2.29M | $3.90M | Reduce |
| Q1 2024 | 2.29M | $6.35M | Hold |
| Q2 2024 | 2.29M | $8.02M | Hold |
| Q3 2024 | 2.29M | $4.56M | Hold |
| Q4 2024 | 2.29M | $3.51M | Hold |
| Q1 2025 | 2.34M | $5.14M | Add |
| Q2 2025 | 2.34M | $4.84M | Hold |
| Q3 2025 | 3.29M | $4.15M | Add |
| Q4 2025 | 3.67M | $4.77M | Add |
| Q1 2026 | 3.75M | $3.00M | Add |
| Q2 2026 | 3.75M | $1.60M | Hold |
| Q3 2026 | 140.86K | $44.16K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HRTX and 13F data
HRTX (HERON THERAPEUTICS INC) is a Health Care company. 7 other funds we track also report a position in HRTX — the largest reported positions include Velan Capital Investment Management LP (US$3.7M), TANG CAPITAL MANAGEMENT LLC (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HRTX
- Velan Capital Investment Management LP 8.75M sh · $3.74M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 6.25M sh · $2.67M · Q2 2026
More on JW Asset Management, LLC
FAQ
How long has JW Asset Management, LLC held HRTX?
JW Asset Management, LLC has disclosed HRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is JW Asset Management, LLC's current position in HRTX?
As of Q3 2026, JW Asset Management, LLC holds 140.86K shares of HRTX (HERON THERAPEUTICS INC), valued at $44.16K, representing 0.02% of its reported portfolio and ranking #29.
Has JW Asset Management, LLC been buying or selling HRTX?
In the latest 13F filing (Q3 2026), JW Asset Management, LLC reduced its position in HRTX. The position peaked in Q2 2024 at 2.29M shares.
Which other funds hold HRTX?
Other major institutional holders of HRTX include Velan Capital Investment Management LP, TANG CAPITAL MANAGEMENT LLC, among 7 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.